10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine
C37H27F3N2O2S — CID 176668715
Data last refreshed: (MolForge compound catalog, from PubChem)
About 10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine
10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine (PubChem CID 176668715) has the molecular formula C37H27F3N2O2S and a molecular weight of 620.70 g/mol. Its IUPAC name is 10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine.
Molecular Properties
| Compound Name | 10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine |
|---|---|
| PubChem CID | 176668715 |
| Molecular Formula | C37H27F3N2O2S |
| Molecular Weight | 620.70 g/mol |
| Exact Mass | 620.17 |
| IUPAC Name | 10-[4-(3,4-dimethoxyphenyl)-5-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-8-yl]phenothiazine |
| SMILES | COc1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3)nc3c(N4c5ccccc5Sc5ccccc54)ccc(C)c23)cc1OC |
| InChI | InChI=1S/C37H27F3N2O2S/c1-22-12-18-30(42-28-8-4-6-10-33(28)45-34-11-7-5-9-29(34)42)36-35(22)26(24-15-19-31(43-2)32(20-24)44-3)21-27(41-36)23-13-16-25(17-14-23)37(38,39)40/h4-21H,1-3H3 |
| InChIKey | SJELMZVVAOPQSI-UHFFFAOYSA-N |
| XLogP | 10.85 |
| TPSA | 34.59 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 620.70 |
| LogP ≤ 5 | 10.85 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176668715 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.